ARMP ARMATA PHARMACEUTICALS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Wed 11 Nov 2026 · estimated
What 3 analyst firms say about ARMATA PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
3 rated views · 3 analyst/firm records · 3 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 3 reports on ARMP from 2 analyst firms in the last 90 days (3 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target and 1 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: JonesTrading raised its target from $15.00 (set 5 Jan 2026) to $20.00 on 27 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| H.C. Wainwright | Joseph Pantginis | Buy | 13 Aug 2026 | 15.00 USD |
| Jonestrading | Debanjana Chatterjee | Buy | 27 Sep 2026 | 20.00 USD |
| Data feed RESEARCH | Research Team | Hold | 18 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:41 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.